Sensorion Shows Protective Effect of SENS-401 in Hearing Loss Models
MONTPELLIER, France, June 29, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner ear diseases, presented data showing that its clinical stage product-candidate SENS-401 demonstrated …